We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Chemical Test Detects Counterfeit Malaria Drugs

By LabMedica International staff writers
Posted on 04 Aug 2014
Print article
Image: The Artesunate Field Test Kit (Photo courtesy of Oregon State University).
Image: The Artesunate Field Test Kit (Photo courtesy of Oregon State University).
A rapid, inexpensive and simple colorimetric-based testing kit for the detection of counterfeit anti-malaria drugs has been developed in order to preserve life and prevent the development of multidrug resistant malaria.

The assay is based on paper microfluidics which offers several advantages over conventional microfluidics, and has great potential to generate inexpensive, easy-to-use, rapid and disposable diagnostic devices and when widely used it could help save hundreds of thousands of lives.

Chemists at the Oregon State University (Corvallis, OR, USA) fabricated a microchip using Whatman filter paper or glass microfiber GF/B (Sigma Aldrich; St. Louis, MO,USA). The filter paper is cut into circular test pads using an 8-mm diameter hole-punch. They designed the paper microchip to enable fluid transport vertically by stacking the paper test pads. Each of the paper cut out has been pretreated by spotting them with different reagents and allowed to dry.

The paper test was divided into layers with the appropriate dried reagents, and the easily prepared sample solution will flow through the regions via capillary action in order to carry out the artesunate detection test. The artesunate sample can then be applied directly onto the test strip/device for measurement. The color will fully develop within minutes so that the user can determine whether artesunate is present in the drug formulation at a therapeutic dose or not. The kit provides a color-coded chart, similar to that accompanying pH paper, which is used to determine the relative concentration of artesunate in the tablet. The paper-based assay, together with the accompanying color chart provides a reliable semi-quantitative measurement of artesunate in a tablet. The rapid, simple, and inexpensive test is especially useful when used as a screening tool for counterfeits in remote areas.

Color measurement of each chip was obtained by using a camera phone application. A sample was applied to the paper chip and allowed to incubate for five minutes for color development. Analysis of the image was performed by measuring the Red, Green, Blue (RGB) value of each spot, and converted to average gray intensity. A single pill can be crushed, dissolved in water, and when a drop of the solution is placed on the paper, it turns yellow if the drug is present. The intensity of the color indicates the level of the drug, which can be compared to a simple color chart.

Vincent T. Remcho, PhD, a professor of chemistry and senior author of the study said, “There are laboratory methods to analyze medications such as this, but they often are not available or widely used in the developing world where malaria kills thousands of people every year. What we need are inexpensive, accurate assays that can detect adulterated pharmaceuticals in the field, simple enough that anyone can use them and our technology should provide that.” The study was published on June 27, 2014, in the journal Talanta.

Related Links:

Oregon State University
Sigma Aldrich


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: Comparison of traditional histopathology imaging vs. PARS raw data (Photo courtesy of University of Waterloo)

AI-Powered Digital Imaging System to Revolutionize Cancer Diagnosis

The process of biopsy is important for confirming the presence of cancer. In the conventional histopathology technique, tissue is excised, sliced, stained, mounted on slides, and examined under a microscope... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.